FDA.reportPublic FDA data

ceftobiprole medocaril sodium 667 MG Injection

RxCUI
2703561
RxNorm name
ceftobiprole medocaril sodium 667 MG Injection
Display name
ceftobiprole medocaril sodium 667 MG Injection
Full name
ceftobiprole medocaril sodium 667 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2bd685df-7dc6-78a6-e063-6294a90a580bceftobiprole medocaril sodium 667 MG Injection [PSN] · ceftobiprole medocaril sodium 667 MG Injection [SCD] · ceftobiprole medocaril sodium 667 MG (equivalent to ceftobiprole 500 MG) Injection [SY]34These highlights do not include all the information needed to use ZEVTERA safely and effectively. See full prescribing information for ZEVTERA. ZEVTERA ® (ceftobiprole medocaril sodium for injection), for intravenous use Initial U.S. Approval: 202420251209